LIFNano Therapeutics
Cambridge
About LIFNano Therapeutics
LIFNano Therapeutics was founded in 2013 as a spin-out from the University of Cambridge, progressing to a clinical stage Nano-Bio-Med company specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor (LIF)..
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.3M
- Last round: Grant (Dec 2016)
- Website: lifnano.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Nanotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/lifnano-therapeutics-177004 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.